NEW YORK (GenomeWeb) – Cynvenio Biosystems said today that it has signed four new distribution agreements for its ClearID line of liquid biopsy tests, making the assays available immediately for patients in Israel, Greece, Argentina, and South Korea.

Pronto Diagnostics will market ClearID in Israel, Karyo in Greece, ProgeniTest in Argentina, and Bio-Medical Science in South Korea.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.